Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

489
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
489
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.2K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.2K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

830
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
830
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

550
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
550
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

564
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
564
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

529
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
529

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel SLC10A2 variants induce primary bile acid malabsorption and dysbiosis with IBD-like features.

Inflammatory bowel diseases·2026
Same author

GPR15-guided CD8<sup>+</sup> T regulatory cells control intestinal inflammation.

Nature·2026
Same author

Return to baseline arsenic concentrations after 1 year on gluten-free diet in children with celiac disease: A prospective cohort study.

JPGN reports·2026
Same author

Codex in Limbo? Using the Interleukin-2 Test to Lower the Bar for Gluten in a Gluten-Free Diet for Celiac Disease.

Gastroenterology·2026
Same author

Hereditary α-tryptasemia; a review of mechanisms linking α-tryptase gene dosage to intestinal homeostasis and immunopathology.

Frontiers in allergy·2026
Same author

Autoantibody signatures in children with celiac disease, juvenile idiopathic arthritis, and polyautoimmunity.

JPGN reports·2026

Related Experiment Video

Updated: Nov 11, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.7K

Celiac Disease: Fallacies and Facts.

Jocelyn A Silvester1,2, Amelie Therrien1, Ciaran P Kelly1

  • 1Celiac Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

The American Journal of Gastroenterology
|March 26, 2021
PubMed
Summary

Celiac disease is common worldwide, and while the gluten-free diet (GFD) is the standard treatment, it has limitations. Research highlights the need for improved management and novel, non-dietary therapies for celiac disease.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.4K

Related Experiment Videos

Last Updated: Nov 11, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.7K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.4K

Area of Science:

  • Gastroenterology
  • Immunology
  • Clinical Medicine

Background:

  • Significant advancements in understanding celiac disease pathophysiology over 25 years.
  • Persistence of misconceptions regarding clinical presentation and management.
  • Availability of global epidemiologic data indicating celiac disease is ubiquitous.

Purpose of the Study:

  • To address persistent fallacies in celiac disease clinical characteristics and management.
  • To highlight the limitations of the gluten-free diet (GFD) as a treatment.
  • To identify opportunities for novel, non-dietary therapeutic approaches.

Main Methods:

  • Review of recent worldwide epidemiologic data on celiac disease prevalence.
  • Analysis of clinical characteristics at diagnosis, including body mass index.
  • Evaluation of the efficacy and limitations of the gluten-free diet (GFD).

Main Results:

  • Celiac disease is a ubiquitous condition with a common elevated body mass index at diagnosis.
  • The gluten-free diet (GFD) is an imperfect treatment, with variable response rates and incomplete efficacy.
  • Symptomatic improvement on a GFD is not diagnostic, and the diet is challenging to maintain.

Conclusions:

  • The gluten-free diet (GFD) presents significant challenges and incomplete efficacy for celiac disease management.
  • Opportunities exist for developing novel, non-dietary treatments to improve patient outcomes.
  • Further research is needed to overcome the limitations of current celiac disease therapies.